Skip to main content

Farallon steps up activism at biotech company Exelixis. Here’s what could happen next

Farallon isn’t an activist investor, but it won’t shy away from a battle if necessary.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.